New study in the journal SLEEP finds a high prevalence of eating disorders in narcolepticsMarch 03, 2008WESTCHESTER, Ill. - The majority of patients with narcolepsy/cataplexy experience a number of symptoms of eating disorders, with an irresistible craving for food and binge eating as the most prominent features, according to a study published in the March 1 issue of the journal SLEEP. The study, authored by Hal Droogleever Fortuyn, MD, and Sebastiaan Overeem, MD, of the Radboud University Nijmegen Medical Center in The Netherlands, focused on 60 patients with narcolepsy/cataplexy who were recruited from specialized sleep centers and 120 healthy controls. According to the results, 23.3 percent of the narcolepsy/cataplexy patients fulfilled the criteria for a clinical eating disorder, as opposed to none of the control subjects. Half of the patients reported a persistent craving for food, as well as binge eating. Twenty-five percent of patients even reported binging at least twice a week. "These data make it clear that narcolepsy is not just a sleeping disorder, but a hypothalamic disease with a much broader symptom profile," said Dr. Fortuyn. "Hypocretin, the neurotransmitter that is lost in narcolepsy, has been implicated in the regulation of feeding through animal studies. Earlier studies in narcolepsy found a clear increase in body weight. However, we did not find a correlation between binge eating and increased weight. Binge eating is apparently not the direct cause of the obesity in narcolepsy, and this suggests that metabolic alterations may be involved. Nevertheless, our study shows that the loss of hypocretin function makes narcolepsy patients not only struggle with staying awake, but also destabilizes their eating pattern, which makes it harder to stay away from the candy jar." Narcolepsy is a sleep disorder that causes people to fall asleep uncontrollably during the day. It also includes features of dreaming that occur while awake. Other common symptoms include sleep paralysis, hallucinations and cataplexy. About one out of every 2,000 people is known to have narcolepsy. It affects the same number of men and women. The American Academy of Sleep Medicine (AASM) offers the following tips on how to get a good night's sleep: * Follow a consistent bedtime routine. * Establish a relaxing setting at bedtime. * Get a full night's sleep every night. * Avoid foods or drinks that contain caffeine, as well as any medicine that has a stimulant, prior to bedtime. * Do not bring your worries to bed with you. * Do not go to bed hungry, but don't eat a big meal before bedtime either. * Avoid any rigorous exercise within six hours of your bedtime. * Make your bedroom quiet, dark and a little bit cool. * Get up at the same time every morning. American Academy of Sleep Medicine |
|||||||||||||||||||||
| Related Narcolepsy Current Events and Narcolepsy News Articles Narcolepsy is an autoimmune disorder, Stanford researcher says Ten years ago, Stanford University School of Medicine scientist Emmanuel Mignot, MD, PhD, and his colleagues made headlines when they identified the culprit behind the sleep disorder narcolepsy. Genetic study confirms the immune system's role in narcolepsy Scientists funded by the National Institutes of Health have identified a gene associated with narcolepsy, a disorder that causes disabling daytime sleepiness, sleep attacks, irresistible bouts of sleep that can strike at any time, and disturbed sleep at night. Treating sleep disorders in people with traumatic brain injury may not eliminate symptoms A study in the April 15 issue of the Journal of Clinical Sleep Medicine is the first to assess the effectiveness of treating sleep disorders in adults with a traumatic brain injury (TBI). Results indicate that treatment may result in the objective resolution of the sleep disorder without improvements in daytime sleepiness or neuropsychological function. Combating weight gain caused by antipsychotic treatments Antipsychotic drugs, such as olanzapine (Zyprexa), risperidone (Risperdal) and quetiapine (Seroquel), are commonly used to treat psychotic disorders like schizophrenia, but also bipolar disorder and even behavioral problems related to dementia. PET imaging focuses on medication's purported ability to improve mental performance Concerned by the growing numbers of people using stimulant medications such as methylphenidate (MP)-either legally or illegally-to improve attention and focus, researchers used positron emission tomography (PET) imaging with the radiotracer fluorodeoxyglucose (FDG) to assess the effects of the drug on brain function in the normal human brain. JCSM: A single subjective question can be an effective sleepiness screening tool A single subjective (SS) question may be an effective screening tool for excessive daytime sleepiness, according to a study published in the April 15 issue of the Journal of Clinical Sleep Medicine (JCSM). Journal SLEEP: Methylphenidate can have sleep benefits in adults with ADHD Treatment with methylphenidate (MPH) appears to have beneficial effects on sleep parameters in adults with ADHD, including increased sleep efficiency and a feeling of improved restorative value of sleep, according to a study published in the March 1 issue of the journal SLEEP. 2 different neural pathways regulate loss and regain of consciousness during general anesthesia University of Pennsylvania School of Medicine researchers have answered long-running questions about the way that anesthetics act on the body, by showing that the cellular pathway for emerging from anesthesia is different from the one that drugs take to put patients to sleep during operations. Practice parameters discuss treatment for narcolepsy, other hypersomnias of central origin Practice parameters published in the December 1 issue of the journal SLEEP serve as both an update of previous practice parameters for the therapy of narcolepsy and as the first practice parameters to address treatment of other hypersomnias of central origin, including idiopathic hypersomnia, recurrent hypersomnia and hypersomnia due to medical condition. Hormone links sleep, hunger and metabolism, researchers find While investigating how the hormone orexin might control sleep and hunger, researchers at UT Southwestern Medical Center have discovered, to their surprise, that it activates a protein, HIF-1, long known to stimulate cancerous tumor growth. More Narcolepsy Current Events and Narcolepsy News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||